IL-12/23 inhibitor Archives - Medical Conferences

Ustekinumab: highly efficacious in PSA independent of methotrexate

Presented By

Dr Michaela Köhm, Goethe-University Frankfurt, Germany

Conference

ACR 2021

14 January, 2022 10:48

Ustekinumab treat-to-target strategy offers long-term alternative for standard-of-care in CD

Presented By

Prof. Laurent Peyrin-Biroulet, University Hospital of Nancy, France

Trial

Phase 3, STARDUST

Conference

UEGW 2021

27 October, 2021 10:09